Hope, Concern Surround WHO Green Light of First Malaria Vaccine

RTS,S has several flaws but could still save tens of thousands of lives, experts say.

katya katarina zimmer
| 10 min read
close-up of a mosquito on human skin

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

ABOVE: © ISTOCK.COM, MRFIZA

Plasmodium parasites are as stealthy as pathogens come. The malaria-causing single-celled organisms have been adapting to the human lineage for longer than our species has existed, giving them millions of years of training in evading our immune systems and—until recently—an unshakable advantage over vaccine developers.

While SARS-CoV-2, the virus that causes COVID-19, only has 29 proteins, Plasmodium species have thousands. SARS-CoV-2’s spike protein, which it uses to invade human cells, is an obvious bullseye for vaccines, but Plasmodium is a moving target. After mosquitoes inject Plasmodium sporozoites into the bloodstream, the parasites hide away and multiply in liver cells, from which they emerge as bloodborne merozoites, which commence fever-inducing invasions of red blood cells. Some of the parasites shapeshift yet again and are picked up through mosquito bites. For each life stage, Plasmodium transforms its cloak of proteins—a challenge to vaccinologists. Many vaccine efforts have failed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • katya katarina zimmer

    Katarina Zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field. Following an internship with The Scientist in 2017, she has been happily freelancing for a number of publications, covering everything from climate change to oncology.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo